Follow the people · Insider
Matthew R. Henn
Matthew R. Henn files insider transactions with the SEC as an officer of Seres Therapeutics (MCRB). We hold 3 disclosed purchases and sales filed since 28 January 2020, 1 of them in the last 90 days.
- Files forMCRB
- Disclosed buys and sells3 in all, 1 in the last 90 days
- Last disclosure18 August 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 26 January 2020 — 17 August 2026Officer · Seres Therapeutics (MCRB)84 Form 4 lines · source: SEC Form 4
Everything they disclosed
84 entries, newest first — one per disclosure report, one per Form 4 line- exercised options over 238 shares of Seres TherapeuticsSEC Form 418 August 2026Common Stock · traded 15 August 2026 · filed 18 August 2026
- ▼ sold on the open market 81 shares of Seres TherapeuticsSEC Form 418 August 2026Common Stock · traded 17 August 2026 · filed 18 August 2026
- exercised options over 140 shares of Seres Therapeutics (a derivative holding)SEC Form 418 August 2026Restricted Stock Units · traded 15 August 2026 · filed 18 August 2026
- exercised options over 98 shares of Seres Therapeutics (a derivative holding)SEC Form 418 August 2026Restricted Stock Units · traded 15 August 2026 · filed 18 August 2026
- was granted 25,000 shares of Seres Therapeutics (a derivative holding)SEC Form 410 July 2026Stock Option (right to buy) · traded 8 July 2026 · filed 10 July 2026
- exercised options over 238 shares of Seres TherapeuticsSEC Form 419 May 2026Common Stock · traded 15 May 2026 · filed 19 May 2026
- ▼ sold on the open market 77 shares of Seres TherapeuticsSEC Form 419 May 2026Common Stock · traded 18 May 2026 · filed 19 May 2026
- exercised options over 141 shares of Seres Therapeutics (a derivative holding)SEC Form 419 May 2026Restricted Stock Units · traded 15 May 2026 · filed 19 May 2026
- exercised options over 97 shares of Seres Therapeutics (a derivative holding)SEC Form 419 May 2026Restricted Stock Units · traded 15 May 2026 · filed 19 May 2026
- was granted 75,000 shares of Seres Therapeutics (a derivative holding)SEC Form 46 March 2026Stock Option (right to buy) · traded 4 March 2026 · filed 6 March 2026
- was granted 75,000 shares of Seres Therapeutics (a derivative holding)SEC Form 46 March 2026Stock Option (right to buy) · traded 4 March 2026 · filed 6 March 2026
- exercised options over 239 shares of Seres TherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- ▼ sold on the open market 89 shares of Seres TherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- exercised options over 141 shares of Seres Therapeutics (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 15 February 2026 · filed 18 February 2026
- exercised options over 141 shares of Seres Therapeutics (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 15 February 2026 · filed 18 February 2026
- exercised options over 98 shares of Seres Therapeutics (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 15 February 2026 · filed 18 February 2026
- exercised options over 98 shares of Seres Therapeutics (a derivative holding)SEC Form 418 February 2026Restricted Stock Units · traded 15 February 2026 · filed 18 February 2026
- exercised options over 239 shares of Seres TherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- ▼ sold on the open market 89 shares of Seres TherapeuticsSEC Form 418 February 2026Common Stock · traded 15 February 2026 · filed 18 February 2026
- exercised options over 3,998 shares of Seres Therapeutics (a derivative holding)SEC Form 418 November 2025Restricted Stock Units · traded 15 November 2025 · filed 18 November 2025
- exercised options over 140 shares of Seres Therapeutics (a derivative holding)SEC Form 418 November 2025Restricted Stock Units · traded 15 November 2025 · filed 18 November 2025
- exercised options over 98 shares of Seres Therapeutics (a derivative holding)SEC Form 418 November 2025Restricted Stock Units · traded 15 November 2025 · filed 18 November 2025
- exercised options over 3,998 shares of Seres TherapeuticsSEC Form 418 November 2025Common Stock · traded 15 November 2025 · filed 18 November 2025
- exercised options over 140 shares of Seres TherapeuticsSEC Form 418 November 2025Common Stock · traded 15 November 2025 · filed 18 November 2025
- exercised options over 98 shares of Seres TherapeuticsSEC Form 418 November 2025Common Stock · traded 15 November 2025 · filed 18 November 2025
- ▼ sold on the open market 1,257 shares of Seres TherapeuticsSEC Form 418 November 2025Common Stock · traded 15 November 2025 · filed 18 November 2025
- was granted 3,998 shares of Seres Therapeutics (a derivative holding)SEC Form 430 September 2025Restricted Stock Units · traded 26 September 2025 · filed 30 September 2025
- exercised options over 141 shares of Seres Therapeutics (a derivative holding)SEC Form 419 August 2025Restricted Stock Units · traded 15 August 2025 · filed 19 August 2025
- exercised options over 97 shares of Seres Therapeutics (a derivative holding)SEC Form 419 August 2025Restricted Stock Units · traded 15 August 2025 · filed 19 August 2025
- exercised options over 141 shares of Seres TherapeuticsSEC Form 419 August 2025Common Stock · traded 15 August 2025 · filed 19 August 2025
- exercised options over 97 shares of Seres TherapeuticsSEC Form 419 August 2025Common Stock · traded 15 August 2025 · filed 19 August 2025
- ▼ sold on the open market 73 shares of Seres TherapeuticsSEC Form 419 August 2025Common Stock · traded 18 August 2025 · filed 19 August 2025
- exercised options over 140 shares of Seres Therapeutics (a derivative holding)SEC Form 419 May 2025Restricted Stock Units · traded 15 May 2025 · filed 19 May 2025
- exercised options over 98 shares of Seres Therapeutics (a derivative holding)SEC Form 419 May 2025Restricted Stock Units · traded 15 May 2025 · filed 19 May 2025
- exercised options over 140 shares of Seres TherapeuticsSEC Form 419 May 2025Common Stock · traded 15 May 2025 · filed 19 May 2025
- exercised options over 98 shares of Seres TherapeuticsSEC Form 419 May 2025Common Stock · traded 15 May 2025 · filed 19 May 2025
- ▼ sold on the open market 77 shares of Seres TherapeuticsSEC Form 419 May 2025Common Stock · traded 16 May 2025 · filed 19 May 2025
- exercised options over 2,813 shares of Seres Therapeutics (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 15 February 2025 · filed 19 February 2025
- exercised options over 7,813 shares of Seres Therapeutics (a derivative holding)SEC Form 419 February 2025Restricted Stock Units · traded 15 February 2025 · filed 19 February 2025
- exercised options over 2,813 shares of Seres TherapeuticsSEC Form 419 February 2025Common Stock · traded 15 February 2025 · filed 19 February 2025
- exercised options over 7,813 shares of Seres TherapeuticsSEC Form 419 February 2025Common Stock · traded 15 February 2025 · filed 19 February 2025
- ▼ sold on the open market 3,953 shares of Seres TherapeuticsSEC Form 419 February 2025Common Stock · traded 18 February 2025 · filed 19 February 2025
- was granted 650,000 shares of Seres Therapeutics (a derivative holding)SEC Form 411 February 2025Stock Option (Right to Buy) · traded 7 February 2025 · filed 11 February 2025
- exercised options over 2,812 shares of Seres Therapeutics (a derivative holding)SEC Form 419 November 2024Restricted Stock Units · traded 15 November 2024 · filed 19 November 2024
- exercised options over 2,812 shares of Seres TherapeuticsSEC Form 419 November 2024Common Stock · traded 15 November 2024 · filed 19 November 2024
- ▼ sold on the open market 927 shares of Seres TherapeuticsSEC Form 419 November 2024Common Stock · traded 18 November 2024 · filed 19 November 2024
- exercised options over 12,622 shares of Seres Therapeutics (a derivative holding)SEC Form 429 October 2024Restricted Stock Units · traded 27 October 2024 · filed 29 October 2024
- exercised options over 12,622 shares of Seres TherapeuticsSEC Form 429 October 2024Common Stock · traded 27 October 2024 · filed 29 October 2024
- ▼ sold on the open market 3,984 shares of Seres TherapeuticsSEC Form 429 October 2024Common Stock · traded 28 October 2024 · filed 29 October 2024
- exercised options over 2,813 shares of Seres Therapeutics (a derivative holding)SEC Form 419 August 2024Restricted Stock Units · traded 15 August 2024 · filed 19 August 2024
- exercised options over 2,813 shares of Seres TherapeuticsSEC Form 419 August 2024Common Stock · traded 15 August 2024 · filed 19 August 2024
- ▼ sold on the open market 923 shares of Seres TherapeuticsSEC Form 419 August 2024Common Stock · traded 16 August 2024 · filed 19 August 2024
- exercised options over 2,812 shares of Seres Therapeutics (a derivative holding)SEC Form 417 May 2024Restricted Stock Units · traded 15 May 2024 · filed 17 May 2024
- exercised options over 2,812 shares of Seres TherapeuticsSEC Form 417 May 2024Common Stock · traded 15 May 2024 · filed 17 May 2024
- ▼ sold on the open market 891 shares of Seres TherapeuticsSEC Form 417 May 2024Common Stock · traded 15 May 2024 · filed 17 May 2024
- was granted 187,500 shares of Seres Therapeutics (a derivative holding)SEC Form 416 February 2024Stock Option (Right to Buy) · traded 14 February 2024 · filed 16 February 2024
- was granted 287,905 shares of Seres Therapeutics (a derivative holding)SEC Form 416 February 2024Stock Option (Right to Buy) · traded 14 February 2024 · filed 16 February 2024
- was granted 31,250 shares of Seres Therapeutics (a derivative holding)SEC Form 416 February 2024Restricted Stock Units · traded 14 February 2024 · filed 16 February 2024
- exercised options over 11,250 shares of Seres Therapeutics (a derivative holding)SEC Form 416 February 2024Restricted Stock Units · traded 15 February 2024 · filed 16 February 2024
- exercised options over 11,250 shares of Seres TherapeuticsSEC Form 416 February 2024Common Stock · traded 15 February 2024 · filed 16 February 2024
- ▼ sold on the open market 4,170 shares of Seres TherapeuticsSEC Form 416 February 2024Common Stock · traded 16 February 2024 · filed 16 February 2024
- was granted 25,245 shares of Seres Therapeutics (a derivative holding)SEC Form 431 October 2023Restricted Stock Units · traded 27 April 2023 · filed 31 October 2023
- exercised options over 12,623 shares of Seres Therapeutics (a derivative holding)SEC Form 431 October 2023Restricted Stock Units · traded 27 October 2023 · filed 31 October 2023
- exercised options over 12,623 shares of Seres TherapeuticsSEC Form 431 October 2023Common Stock · traded 27 October 2023 · filed 31 October 2023
- ▼ sold on the open market 3,886 shares of Seres TherapeuticsSEC Form 431 October 2023Common Stock · traded 30 October 2023 · filed 31 October 2023
- was granted 35,000 shares of Seres Therapeutics (a derivative holding)SEC Form 41 May 2023Stock Option (Right to Buy) · traded 27 April 2023 · filed 1 May 2023
- was granted 45,000 shares of Seres Therapeutics (a derivative holding)SEC Form 47 February 2023Restricted Stock Units · traded 3 February 2023 · filed 7 February 2023
- was granted 90,000 shares of Seres Therapeutics (a derivative holding)SEC Form 47 February 2023Stock Option (Right to Buy) · traded 3 February 2023 · filed 7 February 2023
- was granted 35,000 shares of Seres Therapeutics (a derivative holding)SEC Form 49 September 2022Stock Option (Right to Buy) · traded 8 September 2022 · filed 9 September 2022
- was granted 47,619 shares of Seres TherapeuticsSEC Form 46 July 2022COMMON STOCK · traded 5 July 2022 · filed 6 July 2022
- was granted 175,000 shares of Seres Therapeutics (a derivative holding)SEC Form 48 February 2022Stock Option (Right to Buy) · traded 4 February 2022 · filed 8 February 2022
- was granted 130,000 shares of Seres Therapeutics (a derivative holding)SEC Form 48 February 2021Stock Option (Right to Buy) · traded 4 February 2021 · filed 8 February 2021
- exercised options over 26,000 shares of Seres Therapeutics (a derivative holding)SEC Form 43 December 2020Stock Option (Right to Buy) · traded 1 December 2020 · filed 3 December 2020
- exercised options over 26,250 shares of Seres Therapeutics (a derivative holding)SEC Form 43 December 2020Stock Option (Right to Buy) · traded 1 December 2020 · filed 3 December 2020
- exercised options over 27,562 shares of Seres Therapeutics (a derivative holding)SEC Form 43 December 2020Stock Option (Right to Buy) · traded 1 December 2020 · filed 3 December 2020
- exercised options over 26,000 shares of Seres TherapeuticsSEC Form 43 December 2020Common Stock · traded 1 December 2020 · filed 3 December 2020
- exercised options over 26,250 shares of Seres TherapeuticsSEC Form 43 December 2020Common Stock · traded 1 December 2020 · filed 3 December 2020
- exercised options over 27,562 shares of Seres TherapeuticsSEC Form 43 December 2020Common Stock · traded 1 December 2020 · filed 3 December 2020
- ▼ sold on the open market 55,706 shares of Seres TherapeuticsSEC Form 43 December 2020Common Stock · traded 1 December 2020 · filed 3 December 2020
- ▼ sold on the open market 26,265 shares of Seres TherapeuticsSEC Form 43 December 2020Common Stock · traded 1 December 2020 · filed 3 December 2020
- ▼ sold on the open market 9,841 shares of Seres TherapeuticsSEC Form 43 December 2020Common Stock · traded 1 December 2020 · filed 3 December 2020
- was granted 300,000 shares of Seres Therapeutics (a derivative holding)SEC Form 431 January 2020STOCK OPTION (RIGHT TO BUY) · traded 29 January 2020 · filed 31 January 2020
- exercised options over 7,500 shares of Seres Therapeutics (a derivative holding)SEC Form 428 January 2020RESTRICTED STOCK UNITS · traded 26 January 2020 · filed 28 January 2020
- exercised options over 7,500 shares of Seres TherapeuticsSEC Form 428 January 2020COMMON STOCK · traded 26 January 2020 · filed 28 January 2020
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.